In contrast to the breast cancer studies that are described above, the ovarian cancer studies analyzed BRCA1-mutated and BRCA2-mutated tumors as a single group, making it impossible to evaluate the contribution of the individual genes. The gene discussed is BRCA2; the disease is ovarian cancer.